EC
ELV icon

Elequin Capital’s Elevance Health ELV Stock Holding History

Elequin Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$73.1K Buy
+189
New +$70.1K ﹤0.01% 280
2022
Q2 		– Sell
-9
Closed -$4K – 407
2022
Q1 		$4K Sell
9
-2
-18% -$914 ﹤0.01% 225
2021
Q4 		$5K Buy
+11
New +$4.63K ﹤0.01% 17

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Sanders Capital
Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Elequin Capital's ELV Position: Q2 2026 in Review

Elequin Capital opened a new position in Elevance Health (ELV) in Q2 2026: 189 shares worth $73.1K. The stake represents ﹤0.01% of the portfolio and ranks #280 among its holdings. This is a return to the name: Elequin Capital previously reported a position in ELV as recently as Q1 2022.

Elequin Capital first reported a position in ELV in Q4 2021 and has held it in 3 quarters since. 1,607 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Elequin Capital held 189 shares of Elevance Health worth $73.1K as of Q2 2026.
  • Elevance Health was a new Elequin Capital position in Q2 2026.
  • Elevance Health made up ﹤0.01% of Elequin Capital's portfolio in Q2 2026, its #280 holding.
  • Elequin Capital first reported a position in Elevance Health in Q4 2021 and has held it in 3 quarters since.
  • 1,607 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Elequin Capital's 13F filing for Q2 2026, filed 13 Aug 2026.